ropinirole hydrochloride has been researched along with 5-hydroxy-2-n,n-dipropylaminotetralin, (s)-isomer in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Antonio, T; Dutta, AK; Johnson, M; Reith, ME | 1 |
Antonio, T; Das, B; Dutta, AK; Luo, D; Reith, ME; Vedachalam, S | 1 |
2 other study(ies) available for ropinirole hydrochloride and 5-hydroxy-2-n,n-dipropylaminotetralin, (s)-isomer
Article | Year |
---|---|
Structure-activity relationship study of N⁶-(2-(4-(1H-Indol-5-yl)piperazin-1-yl)ethyl)-N⁶-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine analogues: development of highly selective D3 dopamine receptor agonists along with a highly potent D2/D3 agoni
Topics: Animals; CHO Cells; Cricetinae; Cricetulus; Drug Discovery; Female; Free Radical Scavengers; HEK293 Cells; Humans; Indoles; Locomotion; Male; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Reserpine; Structure-Activity Relationship; Substrate Specificity; Thiazoles | 2012 |
Development of a Highly Potent D2/D3 Agonist and a Partial Agonist from Structure-Activity Relationship Study of N(6)-(2-(4-(1H-Indol-5-yl)piperazin-1-yl)ethyl)-N(6)-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine Analogues: Implication in the Treat
Topics: Animals; Antiparkinson Agents; Benzothiazoles; Cell Line; Drug Discovery; Female; Humans; Locomotion; Male; Neuroprotective Agents; Parkinson Disease; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Structure-Activity Relationship | 2015 |